Abcam
British biotechnology company
Updates & Highlights
BioPharma APAC · 15 days ago
Abcam and EpiCypher Partner to Advance High-Confidence Epigenomics Research
Manufacturing Chemist · 17 days ago
Abcam and EpiCypher partner to develop ChIC/CUT&RUN reagents
marketscreener.com · about 1 month ago
ABCAM LIMITED Announces Termination of Markus Lusser as Director, Effective June 5, 2026
Recent Openings
View all 1 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Health Insurance
Medical, dental & vision
Learning Budget
Professional development
Generous PTO
Paid time off
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Remote Work
Work from anywhere flexibility
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Abcam?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
12 recentAbcam and EpiCypher Partner to Advance High-Confidence Epigenomics Research
Abcam and EpiCypher Partner to Advance High-Confidence Epigenomics Research
BioPharma APAC · 15 days ago
Abcam and EpiCypher partner to develop ChIC/CUT&RUN reagents
Abcam and EpiCypher partner to develop ChIC/CUT&RUN reagents
Manufacturing Chemist · 17 days ago
ABCAM LIMITED Announces Termination of Markus Lusser as Director, Effective June 5, 2026
ABCAM LIMITED Announces Termination of Markus Lusser as Director, Effective June 5, 2026
marketscreener.com · about 1 month ago
Abcam Launches Next-Gen ELISA, Wider Dynamic Range Delivers Results in Less Time
Abcam Launches Next-Gen ELISA, Wider Dynamic Range Delivers Results in Less Time
Contract Pharma · 3 months ago
Abcam wins three recognitions at the 2026 CiteAb Awards
Abcam wins three recognitions at the 2026 CiteAb Awards
Abcam · 4 months ago
Sustainability at Abcam: environmental commitment
Sustainability at Abcam: environmental commitment
Abcam · 4 months ago
Abcam joins the Innovative Health Initiative LIGAND-AI project to advance artificial intelligence (AI)-driven drug discovery through open science
Abcam joins the Innovative Health Initiative LIGAND-AI project to advance artificial intelligence (AI)-driven drug discovery through open science
PR Newswire · 6 months ago
How Abcam is leading the way in antibody performance
How Abcam is leading the way in antibody performance
Abcam · about 1 year ago
Abcam to open office in Shanghai, China
Abcam to open office in Shanghai, China
Abcam · over 1 year ago
Dr Sater on advancing cancer research with Abcam
Dr Sater on advancing cancer research with Abcam
Abcam · almost 2 years ago
Danaher to buy antibody supplier Abcam for $5.7B
Danaher to buy antibody supplier Abcam for $5.7B
MedTech Dive · almost 3 years ago
ABCAM PLC: Trading Update
ABCAM PLC: Trading Update
PR Newswire · over 3 years ago